GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Bioperfectus Technologies Co Ltd (SHSE:688399) » Definitions » Deferred Policy Acquisition Costs

Jiangsu Bioperfectus Technologies Co (SHSE:688399) Deferred Policy Acquisition Costs


View and export this data going back to 2019. Start your Free Trial

What is Jiangsu Bioperfectus Technologies Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Jiangsu Bioperfectus Technologies Co Business Description

Traded in Other Exchanges
N/A
Address
3rd floor, Block G19, No.1 Yaocheng Avenue, Jiangsu, Taizhou, CHN
Jiangsu Bioperfectus Technologies Co Ltd is engaged in product development, production and sales of disease prevention and control, female genital micro-ecological testing and tumor screening. Its products portfolio includes Fever respiratory pathogen detection series, Fever with a rash pathogen test series, Fever with bleeding pathogen test series, Foodborne diseases and diarrheal pathogen detection and Other types of pathogen detection series.
Executives
Jin Jing Supervisors